23andMe Holding Co. (ME)
NASDAQ: ME · Real-Time Price · USD
3.380
+0.230 (7.30%)
Nov 21, 2024, 12:16 PM EST - Market open
23andMe Holding Co. Market Cap
23andMe Holding Co. has a market cap or net worth of $86.55 million as of November 21, 2024. Its market cap has decreased by -79.37% in one year.
Market Cap
86.55M
Enterprise Value
26.47M
1-Year Change
-79.37%
Ranking
Category
Stock Price
$3.35
Market Cap Chart
Since November 23, 2020, 23andMe Holding Co.'s market cap has decreased from $622.97M to $86.55M, a decrease of -86.11%. That is a compound annual growth rate of -39.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 93.76M | -78.58% |
| Dec 29, 2023 | 437.66M | -55.52% |
| Dec 30, 2022 | 983.85M | -67.98% |
| Dec 31, 2021 | 3.07B | 322.89% |
| Dec 31, 2020 | 726.59M | 16.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chimerix | 79.14M |
| MDxHealth | 78.97M |
| Renovaro | 78.39M |
| OptimizeRx | 77.37M |
| Clearside Biomedical | 77.36M |
| Quince Therapeutics | 77.00M |
| Oncolytics Biotech | 76.26M |
| Werewolf Therapeutics | 76.20M |